Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. Its products include genetic engineering vaccines and multivalent vaccines. The company also provides technical services. Pulike Biological Engineering was founded in 1995 and is headquartered in Luoyang, China.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

Shandong XINDE Technology Co. Ltd. is a private company headquartered in Weifang, China, that manufactures pharmaceutical products.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Wuhan Keqian Biology is involved in the research and development, production, and sale of veterinary biological products, as well as the provision of technical services for the prevention of animal epidemics. They offer products including a combination vaccine, a vaccine for poultry, a pet vaccine, and a diagnostic reagent.

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women��s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer��s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Qingdao Xinde Pharmaceutical Co., Ltd., established on 2002-04-24, Business scope includes sales of veterinary biological products,research and development(According to the approval issued by the animal husbandry and veterinary department<Veterinary drug business license>Carry out business activities),Sales:veterinary medicine(According to the approval issued by the animal husbandry and veterinary department<Veterinary drug business license>Carry out business activities),Feed additives,feed,Farming Equipment,pet food,Toy,crafts,Import and export(Projects prohibited by laws and administrative regulations shall not be operated,Operations after permits for projects restricted by laws and administrative regulations),Farming technical service,technical consulting,Animal Health Technical Services,technical consulting,Realtor.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Crist��lia Produtos Qu��micos Farmac��uticos Ltda. develops and manufactures pharmaceutical products. It offers its products for algology, primary care practice, dermatology, geriatrics, gynecology, neurology, oncology, orthopedics, psychiatry, rheumatology and urology. The company was founded in 1972 and is headquartered in Itapira, Brazil.

FAPESP is a public foundation, funded by the taxpayer in the State of São Paulo, with the mission to support research projects in higher education and research institutions, in all fields of knowledge. São Paulo has a population of forty million and generates 35% of Brazil’s GNP. The constitution of the State establishes that 1% of all state taxes belong to the foundation and the government transfers these funds monthly. The stability of the funding and the autonomy of the foundation allow for an efficient management of the resources that has had a sizable impact: while São Paulo has 22% of the Brazilian population and 30% of the scientists with a doctorate in the country, the state responds for 52% of the country’s scientific articles published in international journals. The Foundation works in close contact with the scientific community: all proposals are peer reviewed with the help of area panels composed of active researchers. Besides funding research in all fields, the foundation supports large research programs in Biodiversity, Bioenergy, Global Climate Change, and in Neurosciences.

Tulane Educational Fund is a private company headquartered in the United States specializing in radio broadcasting stations.

Intervet International BV engages in the manufacture and marketing of animal health products. It offers vaccines, anti-infectives, anti-parasitics, feed additives and products for fertility management. The firm products are used for treatment and care of poultry, pigs, cattle, sheep, goats, horses, fish, shrimp and companion animals. The company was founded by Wim Hendrix in 1949 and is headquartered in Boxmeer, the Netherlands.

Harbin Pharmaceutical Group Biological Vaccine Co., Ltd., established on 1992-07-28, The business scope includes the production of veterinary drugs,Veterinary drug business,animal clinics;pet grooming;Sales of liquid paraffin,heating;farming,Forest,Pasture products,pet food,supplies;Research and development of biological products technology,transfer,consult,Serve;Veterinary Technical Services;rental car,houses,venue;poultry farming;Feed additives,Research and development of additive premixed feed,Production,Sales;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).

Seqirus has manufacturing facilities on three continents and a globally integrated supply chain to ensure that the influenza vaccine is delivered on time to customers. They have one of the industry's most extensive influenza vaccination portfolios, customized to the needs of health care providers and their patients.

Qingdao Yebio Bioengineering Co. Ltd. is a Chinese private company located in Qingdao. The firm engages in research and development, production and distribution of veterinary bioproducts for animal disease prevention, diagnosis and treatment.

Autoimmune Technologies LLC develops medical diagnostic tests. It explores disease mechanisms, and investigates therapies for autoimmune diseases, disorders and anti-viral drugs. The company was founded in 1995 and is headquartered in New Orleans, LA.

MaxiVAX is a Swiss clinical-stage biotechnology company, currently performing a first-in-man (phase I) trial in various tumours with MVX-ONCO-1. MaxiVAX’ mission is to develop alternative solutions to “established cancer therapies” that are more effective, are personalized and enable the patient to fight his own disease. MaxiVAX’ first treatment, MVX-ONCO-1 has been classified as an Advanced Therapeutic Product by the European Medicines Agency. The resulting approval procedure is different than that of a traditional drug and should generally allow a faster development until market approval with fewer and less extensive clinical trials.

Guangzhou Enbao Biomedical Technology Co., Ltd., established on 2012-04-25, Business scope includes engineering and technology research and experimental development;Natural science research and experimental development;Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Research and development of bio-based materials technology;Manufacturing of bio-based materials;Sales of bio-based materials;